BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29331658)

  • 1. Sulforaphene Enhances The Efficacy of Photodynamic Therapy In Anaplastic Thyroid Cancer Through Ras/RAF/MEK/ERK Pathway Suppression.
    Chatterjee S; Rhee Y; Chung PS; Ge RF; Ahn JC
    J Photochem Photobiol B; 2018 Feb; 179():46-53. PubMed ID: 29331658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination with genistein enhances the efficacy of photodynamic therapy against human anaplastic thyroid cancer cells.
    Ahn JC; Biswas R; Chung PS
    Lasers Surg Med; 2012 Dec; 44(10):840-9. PubMed ID: 23143780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
    Kim H; Kim SW; Seok KH; Hwang CW; Ahn JC; Jin JO; Kang HW
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():15-21. PubMed ID: 30118906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.
    Biswas R; Chung PS; Moon JH; Lee SH; Ahn JC
    Lasers Med Sci; 2014 May; 29(3):995-1007. PubMed ID: 24114422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of synergistic effects of sulforaphene with photodynamic therapy in human cervical cancer cell line.
    Biswas R; Mondal A; Chatterjee S; Ahn JC
    Lasers Med Sci; 2016 Nov; 31(8):1675-1682. PubMed ID: 27485253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice.
    Biswas R; Mondal A; Ahn JC
    J Photochem Photobiol B; 2015 Jul; 148():118-127. PubMed ID: 25910816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
    Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
    Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aminolevulinic acid photodynamic therapy reduces HPV viral load via autophagy and apoptosis by modulating Ras/Raf/MEK/ERK and PI3K/AKT pathways in HeLa cells.
    Xie J; Wang S; Li Z; Ao C; Wang J; Wang L; Peng X; Zeng K
    J Photochem Photobiol B; 2019 May; 194():46-55. PubMed ID: 30925276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphene-Carboplatin Combination Synergistically Enhances Apoptosis by Disruption of Mitochondrial Membrane Potential and Cell Cycle Arrest in Human Non-Small Cell Lung Carcinoma.
    Chatterjee S; Rhee YH; Ahn JC
    J Med Food; 2016 Sep; 19(9):860-9. PubMed ID: 27467015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma.
    Milosevic Z; Pesic M; Stankovic T; Dinic J; Milovanovic Z; Stojsic J; Dzodic R; Tanic N; Bankovic J
    Transl Res; 2014 Nov; 164(5):411-23. PubMed ID: 25016932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells
    Jo S; Ha TK; Han SH; Kim ME; Jung I; Lee HW; Bae SK; Lee JS
    Anticancer Res; 2017 Apr; 37(4):1705-1710. PubMed ID: 28373432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
    Tong Z; Singh G; Rainbow AJ
    Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
    Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
    BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
    Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS
    Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy.
    Chelakkot VS; Som J; Yoshioka E; Rice CP; Rutihinda SG; Hirasawa K
    Br J Cancer; 2019 Oct; 121(9):758-767. PubMed ID: 31551581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of photodynamic therapy for lung cancers.
    Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
    Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulforaphene Synergistically Sensitizes Cisplatin via Enhanced Mitochondrial Dysfunction and PI3K/PTEN Modulation in Ovarian Cancer Cells.
    Biswas R; Ahn JC; Kim JS
    Anticancer Res; 2015 Jul; 35(7):3901-8. PubMed ID: 26124336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphene suppresses growth of colon cancer-derived tumors via induction of glutathione depletion and microtubule depolymerization.
    Byun S; Shin SH; Park J; Lim S; Lee E; Lee C; Sung D; Farrand L; Lee SR; Kim KH; Dong Z; Lee SW; Lee KW
    Mol Nutr Food Res; 2016 May; 60(5):1068-78. PubMed ID: 26918318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene blue-mediated photodynamic therapy enhances apoptosis in lung cancer cells.
    Lim EJ; Oak CH; Heo J; Kim YH
    Oncol Rep; 2013 Aug; 30(2):856-62. PubMed ID: 23708127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.